Pulmonary embolism in a patient with neuroleptic malignant syndrome

Area of Science:

• Pharmacology
• Cardiology
• Neurology

Background:

• Venous thromboembolism (VTE) is a known complication associated with antipsychotic medications.
• Neuroleptic Malignant Syndrome (NMS) is a rare but serious adverse effect of these drugs.
• Patients on antipsychotics require vigilant monitoring for VTE, even with standard prophylaxis.

Purpose of the Study:

• To highlight a case of pulmonary embolism in a patient with NMS on antipsychotics.
• To emphasize the need for heightened VTE suspicion in this patient group.
• To underscore the importance of comprehensive preventive strategies against VTE.

Main Methods:

• Case report of a young patient experiencing NMS and pulmonary embolism.
• Review of standard care measures including thromboprophylaxis and early mobilization.
• Analysis of the clinical presentation and management challenges.

Main Results:

• A young patient developed pulmonary embolism despite standard VTE prophylaxis and early mobilization.
• The patient presented with Neuroleptic Malignant Syndrome following initiation of antipsychotic therapy.
• This case illustrates a severe VTE complication occurring in a complex clinical scenario.

Conclusions:

• A low threshold for VTE suspicion is essential in patients prescribed antipsychotics, particularly those with NMS.
• Effective and potentially enhanced preventive measures are necessary to mitigate VTE risk.
• Preventing VTE in this vulnerable population requires a multi-faceted approach beyond standard care.